Search Results for: ITGB1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ITGA10 integrin subunit alpha 10
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • CHL1 interactions
  • Platelet Adhesion to exposed collagen
ITGA11 integrin subunit alpha 11
  • Integrin cell surface interactions
  • Integrin cell surface interactions
ITGA2 integrin subunit alpha 2
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Laminin interactions
  • Laminin interactions
  • Syndecan interactions
  • ECM proteoglycans
  • CHL1 interactions
  • Platelet Adhesion to exposed collagen
  • MET activates PTK2 signaling
  • Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition
ITGA3 integrin subunit alpha 3
  • Basigin interactions
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Laminin interactions
  • MET activates PTK2 signaling
ITGA4 integrin subunit alpha 4
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • RUNX3 Regulates Immune Response and Cell Migration
  • Potential therapeutics for SARS
  • Natalizumab
  • ATL1102
  • CDP323
  • R1295
  • R411
  • Tinzaparin
  • Vedolizumab
  • MK-0668
ITGA5 integrin subunit alpha 5
  • Elastic fibre formation
  • Fibronectin matrix formation
  • Cell surface interactions at the vascular wall
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Signal transduction by L1
  • RUNX2 regulates genes involved in cell migration
  • GPER1 signaling
  • Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Resveratrol
  • Tauroursodeoxycholic acid
ITGA6 integrin subunit alpha 6
  • Assembly of collagen fibrils and other multimeric structures
  • Basigin interactions
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Laminin interactions
  • Laminin interactions
  • Syndecan interactions
  • Type I hemidesmosome assembly
  • Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
  • Developmental Lineage of Mammary Gland Luminal Epithelial Cells
  • Developmental Lineage of Mammary Gland Alveolar Cells
  • Developmental Lineage of Mammary Gland Myoepithelial Cells
  • Developmental Lineage of Mammary Stem Cells
  • Epidermolysis bullosa, junctional, including: Epidermolysis bullosa, junctional, Herlitz type (JEB-H); Epidermolysis bullosa, junctional, non-Herlitz type (JEB-nH); Epidermolysis bullosa, junctional, with pyloric atresia (JEB-PA)
ITGA8 integrin subunit alpha 8
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • TGF-beta receptor signaling activates SMADs
  • ECM proteoglycans
  • Formation of the ureteric bud
ITGA9 integrin subunit alpha 9
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • ECM proteoglycans
  • Signal transduction by L1
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
ITGAV integrin subunit alpha V
  • Cross-presentation of particulate exogenous antigens (phagosomes)
  • Elastic fibre formation
  • PECAM1 interactions
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • TGF-beta receptor signaling activates SMADs
  • Laminin interactions
  • Syndecan interactions
  • Syndecan interactions
  • ECM proteoglycans
  • VEGFA-VEGFR2 Pathway
  • Signal transduction by L1
  • Neutrophil degranulation
  • Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Antithymocyte immunoglobulin (rabbit)
  • Levothyroxine
  • PLN-74809
ITGB1BP1 integrin subunit beta 1 binding protein 1
ITGB1BP2 integrin subunit beta 1 binding protein 2
LAMA1 laminin subunit alpha 1
  • Laminin interactions
  • Laminin interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • L1CAM interactions
  • MET activates PTK2 signaling
  • Attachment of bacteria to epithelial cells
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Formation of the dystrophin-glycoprotein complex (DGC)
  • Developmental Lineage of Pancreatic Ductal Cells
  • Lanoteplase
LAMTOR5 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
  • Macroautophagy
  • MTOR signalling
  • mTORC1-mediated signalling
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of PTEN gene transcription
  • Amino acids regulate mTORC1
LGALS1 galectin 1
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Mercaptoethanol
  • Thiodigalactoside
  • 1,4-Dithiothreitol
  • Artenimol
  • OTX-008
LGALS3BP galectin 3 binding protein
  • Platelet degranulation
LGALS8 galectin 8
MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4
  • Oxidative Stress Induced Senescence
  • Fostamatinib
MET MET proto-oncogene, receptor tyrosine kinase
  • PIP3 activates AKT signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Sema4D mediated inhibition of cell attachment and migration
  • RAF/MAP kinase cascade
  • MET Receptor Activation
  • Negative regulation of MET activity
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • MET activates RAS signaling
  • MET activates PI3K/AKT signaling
  • MET activates PTPN11
  • MET activates PTK2 signaling
  • InlB-mediated entry of Listeria monocytogenes into host cell
  • InlB-mediated entry of Listeria monocytogenes into host cell
  • MET interacts with TNS proteins
  • MET activates RAP1 and RAC1
  • MET receptor recycling
  • MET activates STAT3
  • MECP2 regulates neuronal receptors and channels
  • Drug-mediated inhibition of MET activation
  • Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
  • Sunitinib
  • K-252a
  • SGX-523
  • 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide
  • N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
  • 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide
  • N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide
  • 3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol
  • AMG-208
  • 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE
  • Crizotinib
  • Cabozantinib
  • Capmatinib
  • Tivozanib
  • Fostamatinib
  • Tivantinib
  • Brigatinib
  • Amuvatinib
  • Tepotinib
  • Amivantamab
  • Cholangiocarcinoma
  • Gastric cancer
  • Renal cell carcinoma
NCKIPSD NCK interacting protein with SH3 domain
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis

Page 3 out of 5 pages